SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-076568
Filing Date
2024-07-01
Accepted
2024-07-01 07:08:35
Documents
15
Period of Report
2024-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2418608d1_8k.htm   iXBRL 8-K 36600
2 EXHIBIT 99.1 tm2418608d1_ex99-1.htm EX-99.1 21059
6 GRAPHIC tm2418608d1_ex99-1img001.jpg GRAPHIC 4368
  Complete submission text file 0001104659-24-076568.txt   245705

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20240629.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20240629_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20240629_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2418608d1_8k_htm.xml XML 3600
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 241088168
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)